2-[(E)-2-(2-methoxyphenyl)ethenyl]pyrazine

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 2-[(E)-2-(2-methoxyphenyl)ethenyl]pyrazine
• 化学式: C₁₃H₁₂N₂O
• 分子量: 212.25
• InChiKey: SJLUMZJBWQRCBV-VOTSOKGWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  35
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• ALPHA-SYNUCLEIN LIGANDS
  申请人：Washington University

  公开号：US20170189566A1

  公开（公告）日：2017-07-06

  The present invention generally relates to various compounds that are useful as α-synuclein ligands. The invention further relates to methods of using these compounds and their radiolabeled analogs for the detection of synucleinopathies, including Parkinson's disease (PD).

  本发明通常涉及作为α-突触核蛋白配体有用的各种化合物。该发明进一步涉及使用这些化合物及其放射标记类似物用于检测突触核蛋白病，包括帕金森病（PD）的方法。
• Anti-Angiogenic Compounds
  申请人：UNIVERSITY COLLEGE DUBLIN - NATIONAL UNIVERSITY OF IRELAND, DUBLIN

  公开号：US20160326122A1

  公开（公告）日：2016-11-10

  Compounds and compositions are described which are useful especially for treatment of angiogenesis-related diseases or disorders such as neovascularisation of the eye, age-related macular degeneration, diabetic retinopathy or cancer.

  描述了一些化合物和组合物，特别适用于治疗与血管生成相关的疾病或疾病，如眼部新血管生成、老年性黄斑变性、糖尿病性视网膜病变或癌症。
• [EN] ANTI-ANGIOGENIC COMPOUNDS<br/>[FR] COMPOSÉS ANTIANGIOGÉNIQUES
  申请人：UNIV DUBLIN

  公开号：WO2015107122A1

  公开（公告）日：2015-07-23

  Compounds of the formula A-X-Y-B and compositions are described which are useful especially for treatment of angiogenesis-related diseases or disorders such as neovascularisation of the eye, age- related macular degeneration, diabetic retinopathy or cancer, wherein A is a six membered heteroaryl ring containing 2 nitrogen atoms which is optionally substituted with R1; R1 is H, CI-6 alkyl, CN, CONR2R3; R2 and R3 which may be the same or different and selected from H, CI-6 alkyl or R2 and R3 form a ring; the group X-Y is an alkyne or alkene, in the case wherein X-Y is an alkene the double bond may be cis or trans and optionally substituted with R1 B is an aryl; or five or six membered heteroaryl ring containing 1 to 3 heteroatoms, both of which may optionally substituted with one or more R4; R4 is R1 or OR5; R5 is H, COR6 or R6; and R6 is CI-6 alkyl and salts thereof.

  描述了化合物A-X-Y-B的结构式和组成物，这些化合物特别适用于治疗与血管生成相关的疾病或疾病，如眼部新血管生成、年龄相关性黄斑变性、糖尿病性视网膜病变或癌症，其中A是一个含有2个氮原子的六元杂环芳基环，可选择地取代为R1；R1为H、CI-6烷基、CN、CONR2R3；R2和R3可以相同也可以不同，选择自H、CI-6烷基或R2和R3形成环；X-Y是炔烃或烯烃，如果X-Y是烯烃，则双键可以为顺式或反式，并可选择地取代为R1；B是芳基；或含有1至3个杂原子的五元或六元杂环芳基环，两者均可选择地取代为一个或多个R4；R4为R1或OR5；R5为H、COR6或R6；R6为CI-6烷基及其盐。
• Alpha-synuclein ligands
  申请人：Washington University

  公开号：US10300155B2

  公开（公告）日：2019-05-28

  The present invention generally relates to various compounds that are useful as α-synuclein ligands. The invention further relates to methods of using these compounds and their radiolabeled analogs for the detection of synucleinopathies, including Parkinson's disease (PD).

  本发明一般涉及可用作α-突触核蛋白配体的各种化合物。本发明还涉及使用这些化合物及其放射性标记类似物检测突触核蛋白病（包括帕金森病）的方法。
• ANTI-ANGIOGENIC COMPOUNDS
  申请人：University College Dublin National University Of Ireland, Dublin

  公开号：EP3094625A1

  公开（公告）日：2016-11-23